Skip to Content

NVR LCL (Afinitor 2.5 mg)

Generic Name: everolimus

Pill imprint NVR LCL has been identified as Afinitor 2.5 mg.

Afinitor is used in the treatment of neuroendocrine carcinoma; brain tumor; breast cancer; tuberous sclerosis; pancreatic cancer (and more), and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Afinitor 2.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Afinitor
Generic Name:
everolimus
Imprint:
NVR LCL
Strength:
2.5 mg
Color:
Yellow
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
MTOR inhibitors
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Novartis Pharmaceuticals
National Drug Code (NDC):
00078-0594
Inactive Ingredients:
butylated hydroxytoluene
crospovidone
hypromelloses
lactose anhydrous
lactose monohydrate
magnesium stearate

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide